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We have identified a region within the 8 CGRP gene which has the potential to encode a novel calcitonin- 
like peptide. The gene is located on the short arm of chromosome 11 (1 lp 12-14.2) and we suggest hat 
it resulted from a local duplication of the a gene. We have been unable to detect he corresponding mRNA 
in a variety of tissues which express a-calcitonin. It is not clear whether this sequence can be expressed in 
man. 
Calcitonin gene relatedpeptide BCGRP gene Calcitonin Gene duplication 
1. INTRODUCTION 
Study of calcitonin gene expression in the rat 
revealed that two different mRNA species can be 
produced from the same primary transcript, one 
encoding calcitonin (CT) and the other calcitonin 
gene related peptide (CGRP) [l]. The 2 mature 
mRNAs share a region at their 5’-end (exons l-3); 
exon 4 is calcitonin-specific and exons 5 and 6 are 
CGRP-specific.’ Similar findings were soon 
reported for the human calcitonin gene [2,3]. 
Recently a second gene generating an mRNA 
related to CGRP has been identified in both rat 
and man [4,5]. This is known as the ,5 CGRP gene 
- the organisation of its mRNA appears to be 
similar to that of a CGRP [4]. While no mRNA 
related to calcitonin has yet been identified from 
this gene, evidence both for and against the ex- 
istence of calcitonin related areas within the fl gene 
has been published [4,6]. The possibility of a se- 
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cond calcitonin arising from the fl gene seemed 
particularly interesting in view of reports that a 
salmon calcitonin-like peptide can be detected in 
normal individuals as well as in patients with small 
cell carcinoma of the lung [7,8]. 
We report here the isolation of a genomic clone 
containing most of the fl CTKGRP gene. We have 
performed in situ hybridisation studies with 
regions lacking strong homology with the (Y gene 
and have shown that it is located close to the cy 
gene on the short arm of chromosome 11 (llp 
12-14.2). We have detected an area of the ,& gene 
which is related to the CT-specific exon of the u 
gene. Despite a 67% homology with exon 4 of the 
(Y gene it does not appear to code for a protein 
similar to the calcitonin precursor and we have 
been unable to detect any mRNA containing this 
sequence. The CT-like region of the p gene does 
however contain an open reading frame of 65 
amino acids. Although this is probably not 
translated it does have considerable homology with 
the mammalian calcitonins. Of particular note is 
the finding that this potential peptide has features 
characteristic of both the bovine and human type 
of calcitonin. 
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2. MATERIALS AND METHODS 
A human genomic library was constructed in h 
EMBL4 using 15-20 kb Sau3A fragments. The 
library was screened with a probe derived from 
phTB58 [9] containing exons 5 and 6 of the cy gene. 
The chain-termination method of Sanger et al. [lo] 
was used for sequencing using “S-labelled dATP. 
Both strands were sequenced in multiple deter- 
minations. Plaque screening and DNA transfers 
were done on nitrocellulose filters hybridising in 
50% formamide, 5 x SSPE (1 x SSPE: 180 mM 
NaCl, 10 mM Na phosphate buffer, pH 7.7, 1 mM 
EDTA), 0.1% dried milk, 0.2% SDS and 10% 
dextran sulphate at 42°C. DNA probes were nick- 
translated to a specific activity of log-lo9 dpm/pg 
DNA using [32P]dCTP. Filters were washed in 
0.1 x SSPE/0.2% SDS at 65°C. For non-stringent 
hybridisation the hybridisation temperature was 
reduced to 35°C and the washing was done in 2 x 
SSPE at 50°C. mRNA was prepared using 
guanidinium/CsCl [ 1 l] and poly(U)-Sepharose 
columns. RNAs were electrophoresed on for- 
maldehyde/agarose gels, transferred to Pall filters, 
and hybridised as for DNA. To reprobe, the filter 
was washed at 80°C for 15 min in 2 mM Tris-HCI, 
pH 8.0, 2 mM EDTA with 0.5% SDS. 
In situ hybridisation: female metaphase 
chromosomes were prepared from peripheral ym- 
phocytes [12] and hybridised with ‘251-labelled 
probes [ 131. Metaphases were banded according to 
Zabel et al. [14], photographed and analysed. 
3. RESULTS 
A library of human genomic clones was con- 
structed and screened with a probe representing 
human cy CGRP. Three clones were identified 
which did not correspond with the known restric- 
tion map of the (Y CTKGRP gene and one of 
these, MGL23, was selected for detailed analysis. 
Areas hybridising strongly with exons 3 and 5 of 
the (Y gene [6,9] were detected in this clone. We 
have now determined the nucleotide sequence of its 
CGRP coding region (not shown) and have con- 
firmed that it is indeed ,& CGRP. Restriction 
fragments lacking strong homology with the cy 
gene were labelled with “‘1 by nick-translation and 
hybridised to human metaphase chromosomes. 
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Specific hybridisation was found to the short arm 
of chromosome 11 in the region llp 12-14.2 
(fig.1). This agrees with the findings of Hoppener 
et al. [15] (11 ql-p ter) and corresponds with the 
position of the LY CT/CGRP gene [16] (11~13-15) 
to within the limits of resolution attainable with a 
12sI-labelled probe. 
Under stringent hybridisation conditions restric- 
tion fragments were identified within the genomic 
clone that gave a weak signal with probes specific 
for the calcitonin coding exon of the (Y gene. Non- 
stringent hybridisation conditions were therefore 
used subsequently and strong signals were ob- 
tained. The nucleotide sequence of this region was 
determined and compared with the corresponding 
sequence of the CY gene (fig.2). The overall 
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Fig. 1. Localization of the fl CGRP gene. 50 metaphases 
were analysed. The average grain count was 1.4 per 
metaphase and 28% of grains were localised on 
chromosome 11. The main histogram shows the grain 
count in the major regions of each chromosome. Inset: 
grain distribution along chromosome 11. Chromosome 
11 has been divided into 8 regions. On the p arm, 
cent-p12, p12-~14.2 and p14.2-p ter; on the q arm, 
cent-q13.1, q13.1-q14, q14-q20, q20-q23 and q23-q 
ter . 
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CCATGGGGACAGTCCCTAGTGCATGGTACTGTCTGGCATGTCC TTCCCTTGCAG 
** **** ****** *** 
GGTATGTGTTTTCCCTC CAG 
CTTGAGCAGTCCTAGATTTAAGTAGCATATAGTAATCTGAGTACCTGCTTGCAGGGCACA 
* ** l ** l * l *** **** * ************* l ** *** ******* 
CCTGGACAGCCCCAGATCTAAGCGGTGCG GTAATCTGAGTACTTGCATGCTGGGCACA __A___ 
TACTTGCAGTACCTGAAAAACTTTCATATGTTCCCTGGCATCAACTTCGGGCCTGAAATT 
*** **** ** * ** ** ***** * ****** * **** ** * 
TACACGCAGGACTTCAACAAGTTTCACACGTTCCCCCAAACTGCAATTGGGGTTGGAGCA 
CCTGGCAAGAATAGGGACATAGTCAACAGC TTGCAGAGGGACCACTACCCG ACTCC 
***** ***** ***** ** *** **** *** **** ***** *** * 
CCTGGAAAGAAAAGGGATAT GTC CAGCGACTTGGAGAGAGACCATCGCCCTCATGTT _____& 
AGGGTCCCCCAGA TGGCAGCTG AACTTCTCTCAACTCT CCTGATTCCCCTTCTTGC 
** * ******* ** ** ** **** *** * ** *** *** ********** 
AGCATGCCCCAGAATGCCAACT AAACTCCTCCCTTTCCTTCCTAATTTCCCTTCTTGCA 
+ ++ 
TCCACTTTAT GAACCTGATGCATGTGGATT CCTCTCTGATTTGTCTTCATGCTGG 
*** ** * *** ************ ** ******** * **** ***** 
TCC TTCCTATAACTTGATGCATGTGGTTTGGTTCCTCTCTGGTGGCTCTTTGGGCTGG 
TATTGGTATTTTTGCTTATGACAGAGAATGTTTTGAAGACCTCAGGATGGAAGGGAAGAC 
******* *** *** l * ***** **** * ** ** *** ***** *** **** 
TATTGGTGGCTTTCCTTGTGGCAGAGGATGTCTC AA ACTTCAAGATGGGAGGAAAGAG 
T 
AGCAGGACTTACTGAACACGTT AGAGA TAAAAGAAAATAAGGG 
********* *** *** ***** ** ******* **** 
AGCAGGACTC ACAGGTTGGAAGAGAATCACCTGGGAAAATACCAGAAAATGAGGG 
AAGCTTCTTGAGACTGT AGAGGGTGTTATGACAGAGGCATCCAATTT CTGCTTCTAAAT 
*** ***** * **** *** ** ***** *** * * ******** *** 
CCGCT TTGAGTCCCCCAGAGA TGTCAT CAGAGC TCCTCTGTCCTGCTTCTGAAT 
GTACTACGATAAAATAAGCACGTCCTTAATGCCTTCGGATTAGATGAATCAT CTATTTTT 
** ** *** *** ** **** * ******* 
GTGCT GAT CATTTGAGGAATAAAATTATTTTT 
-----_ 
CTAA AAGGA CTGAGCTGCGGTGCTCATTGCTCTGGTAC = BETA 
* ** ** ******** **** l ********** * 
cccc AAAGATCTGAGCTGTGGTGGTCATTGCTCTGATCT = ALPHA 
Fig.2. The fl gene calcitonin-like region. The nucleotide sequence of exon 4 of the LY gene [6,9] is shown aligned with 
the corresponding region of the B gene. Important features are indicated as follows: (I) limits of exon 4; (- - -) codons 
for paired dibasic amino acids bounding calcitonin sequence; (+++) termination triplet of CY gene; (- --) poly(A) 
addition sequence; (*) common residues. Residue 407 in the fl gene sequence is uncertain, giving clear but conflicting 
data when the 2 strands were sequenced. 
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Fig.3. Northern blot analysis of human mRNA samples. 
(A) Probing with /3 gene sequence; (B) probing the same 
filter with cu-calcitonin probe. Tracks: 1, 3 /rg BEN cell 
mRNA (bronchial carcinoma [21]); 2,3 fig HL60 mRNA 
(leukaemia cell line); 3, 3 pg phaeochromocytoma 
mRNA; 4, 0.5 pg sporadic type medullary thyroid 
carcinoma; 5, 0.5 pg familial type medullary thyroid 
carcinoma. 
homology is 67.6%. The calcitonin coding se- 
quence has not been conserved to a greater degree 
than other regions and in fact, over its first 200 
bases, the 3 ‘-non-coding region shows slightly 
more homology with its fl counterpart. 
As thefl gene sequence contains an open reading 
frame of 65 amino acids (see below) the possibility 
that it might be expressed could not be ignored. A 
Northern blot was performed with mRNA from 
various tissues where expression might be ex- 
pected. No signal was detected on the filter after 3 
weeks exposure (fig.3A). The same filter was then 
reprobed with an a-calcitonin-specific probe 
(fig.3B). Calcitonin message was detected after 2 
days exposure. 
4. DISCUSSION 
We have presented the structure of the 
calcitonin-like region of the gene encoding ,& 
CGRP. The principal interest in this region lies in 
the possibility that it encodes a previously uniden- 
tified regulatory peptide. Our attempts to detect an 
mRNA representing this region were unsuccessful 
(fig.3) but this must be treated with caution since 
we cannot know where or at what level such an 
mRNA might be expressed. 
If this sequence is to be expressed in the manner 
of the calcitonin coding exon of the CY gene then it 
would be excised from a much longer transcript. It 
is known that the fl gene has a high degree of 
homology with exons 3 and 5 of the LY gene [4] and 
that these are spliced together to producefl CGRP. 
The splice donor signals at the 3 ’ -end of exon 3 are 
therefore functional and if suitable signals exist 
around the exon 4-like sequence then an alternate 
mRNA could be produced. The consensus se- 
quence preceding a splice acceptor site is 
(Y)iiNYAG (Y = pyrimidine, N = any base) [17] 
and sequences conforming precisely to this 
paradigm are found before both cy and fl gene se- 
quences in fig.2. The other likely requirement for 
the production of a message would be the conser- 
vation of sequences involved in the formation of 
the polyadenylated 3 ’ -terminus. Such sequences 
are believed to comprise both the region preceding 
the polyadenylation site (including the hex- 
anucleotide AATAAA) and sequences beyond this 
point [ 181. The former is a region of strikingly low 
homology between a and P genes whilst the latter 
shows 87% homology. It seems unlikely that nor- 
mal processing can occur at this site but the 
possibility cannot be ruled out. 
If a calcitonin-like mRNA were somehow pro- 
duced then the reading frame of the protein would 
be defined by the 3/4 splice and, since fl CGRP 
would share the same splice donor site in exon 3, 
we can deduce the reading frame from that of ,f3 
CGRP [4]. This reading frame terminates after on- 
ly 8 amino acids. There is an open reading frame 
of 65 amino acids which starts at position 76 of 
fig.2. We have considered the possibility of its ex- 
pression from an alternative splice acceptor site 
but there is no other suitable sequence. It therefore 
seems unlikely that this sequence is expressed in 
man. However, it is possible that the predicted 
peptide or a close homologue would have useful 
biological properties. A stretch of 33 amino acids 
shows homology with the calcitonins though this 
region is not flanked by paired dibasic amino acids 
as would be expected if it were to be cleaved from 
a larger precursor protein. 
Three types of calcitonin (salmon, bovine and 
human) have been described [19,20] and a com- 
parison with the fi gene peptide is presented in 
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Fig.4. Comparison of fl gene peptide with calcitonins. The predicted fl gene peptide (4) is compared with the 3 known 
types of cakitonin sequence. Consensus human type (l), salmon type (2) and bovine type (3) calcitonin sequences were 
compiled from published sources [ 19,201, selecting the most abundant residue within each group. Where 2 amino acids 
were equally frequent, he one found in other types was chosen and in the one case where this did not permit assignment, 
the human amino acid was chosen rather than the rat. 
fig.4. The ,& gene peptide has specific features in 
common with both mammalian-type sequences 
and might be considered as a separate type. The 
homology of the exon 4-like DNA with the a gene 
is roughly constant at 67% throughout its length 
(fig. 1). This is comparable with the CGRP 3 ‘-non- 
coding sequences (65% homologous) and in 
marked contrast to the CGRP coding sequences 
which are 92% homologous [4]. We suggest 
therefore that the ,& gene may have arisen from a 
gene duplication on the short arm of chromosome 
11. The exon 4-like region of the new gene then lost 
its potential to code for a calcitonin. Whether the 
fi gene is now committed only to CGRP produc- 
tion or has some other alternative product is a 
question whose answer must await complete se- 
quencing of the gene. 
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